Point72 (DIFC)’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,438	Closed	-$152K	–	1102
2024 Q4	$152K	Buy	7,438 +7,383	+13,424%	+$150K	0.01%	413
2024 Q3	$1.61K	Buy	+55	New	+$1.61K	﹤0.01%	809